Ultragenyx Pharmaceutical | Capitale Ordinario



Ordinary Share Capital Cambiamento Data
Acadia Pharmaceuticals USD 16K 0 2024-12
Agios Pharmaceuticals USD 73K 0 2024-12
Alnylam Pharmaceuticals USD 1.29M 4K 2024-12
BioMarin Pharmaceutical USD 191K 0 2024-12
Insmed USD 1.79M 6K 2024-12
Ionis Pharmaceuticals USD 158K 0 2024-12
Kyowa Hakko Kirin JPY 26.74B 0 2024-12
MacroGenics USD 628K 1000 2024-12
Moderna USD 38.6K 100 2024-12
Neurocrine Biosciences USD 100K 0 2024-12
PTC Therapeutics USD 77K 1000 2024-12
Regeneron Pharmaceuticals USD 100K 2K 2024-09
Sarepta Therapeutics USD 10K 0 2024-12
Ultragenyx Pharmaceutical USD 92K 0 2024-12
Vertex Pharmaceuticals USD 2.6M 0 2024-12



Ultragenyx Pharmaceutical Capitale Ordinario - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2025.